Chester County News and Community Website
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced encouraging interim results from its global Phase 1b FURTHER trial, presented at the prestigious IASCLC 2024 World Conference on Lung …
ArriVent BioPharma Unveils Promising Phase 1b Data for Firmonertinib in Treating NSCLC Read More
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) has revealed groundbreaking clinical data on its novel therapeutic agent, PRT3789, at the European Society of Medical Oncology (ESMO) Congress 2024 in Barcelona. …
Prelude Therapeutics Unveils Promising Data on PRT3789 at ESMO Congress 2024 Read More
PHOENIXVILLE, PA — PleoPharma, Inc. has announced promising results from a Phase 2b study evaluating its leading drug candidate, PP-01, intended for mitigating Cannabis Withdrawal Syndrome. Conducted across 22 US addiction …
PleoPharma’s PP-01 Shows Promise in Treating Cannabis Withdrawal Syndrome Read More
KING OF PRUSSIA, PA — CluePoints has announced the full agenda and speaker lineup for the highly anticipated RBQMLive 2024. Scheduled for September 24-25, this virtual event promises an in-depth exploration …
CluePoints Unveils RBQMLive 2024 Agenda: A Pivotal Event for Clinical Trial Innovation Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the successful completion of patient enrollment in its SEISMiC Extension Phase 2b study. This research focuses on istaroxime, a promising therapy …
Windtree Therapeutics Advances Heart Failure Treatment with SEISMiC Extension Study Completion Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reached a significant milestone in its GARDian clinical trial for OCU410ST, a promising gene therapy aimed at treating Stargardt disease. The company …
Ocugen Advances Gene Therapy Trial for Stargardt Disease Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received approval from Health Canada to begin the Phase 3 liMeliGhT clinical trial for their OCU400 gene therapy. This trial aims to …
Ocugen Expands Gene Therapy Trial to Canada Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) recently announced the publication of a new retrospective analysis demonstrating the benefits of the Titan SGS™ Stapler in laparoscopic sleeve gastrectomy (LSG). Conducted by …
Teleflex Publishes New Study Highlighting Benefits of Titan SG Stapler in Laparoscopic Sleeve Gastrectomy Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced this week that Part 2 of its Phase 2 clinical trial for VP-315, a potential first-in-class oncolytic peptide, has yielded …
Verrica Pharmaceuticals Reports Promising Phase 2 Results for VP-315 in Basal Cell Carcinoma Read More
BERWYN, PA — Panavance Therapeutics Inc. has announced the publication of encouraging data on misetionamide in the peer-reviewed journal, Cancer Medicine. The study conducted by Kim et al. at MD …
Panavance Therapeutics Reports Positive Data on Misetionamide in Ovarian Cancer Read More